Beardsley Robert A sold ABUS

October 1, 2026 · Form 4 insider transaction

Beardsley Robert A sold 17,948 shares of Arbutus Biopharma Corporation at $5.00 per share, a transaction worth $89.7K. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 6 days after the transaction.

Direction
Disposed (sell-side)
Shares
17,948
Price
$5.00
Total value
$89.7K
Role—
SecurityCommon Shares
Transaction codeD: Disposition to the issuer
Transaction dateOctober 1, 2026
Filing dateOctober 7, 2026
Shares owned after14,328
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents common shares tendered to the Issuer pursuant to the Issuer's tender offer. The Issuer took up and accepted the common shares for payment on October 1, 2026.

View the original Form 4 on SEC EDGAR